Cite
HARVARD Citation
Lentz, S. et al. (n.d.). Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A. Haemophilia. pp. e445-e449. [Online].